Compounds > sb 203580
Page last updated: 2024-09-05

sb 203580 and 5'-(4-fluorosulfonylbenzoyl)adenosine

sb 203580 has been researched along with 5'-(4-fluorosulfonylbenzoyl)adenosine in 1 studies

Compound Research Comparison

Studies
(sb 203580)		Trials
(sb 203580)		Recent Studies (post-2010)
(sb 203580)		Studies
(5'-(4-fluorosulfonylbenzoyl)adenosine)		Trials
(5'-(4-fluorosulfonylbenzoyl)adenosine)		Recent Studies (post-2010) (5'-(4-fluorosulfonylbenzoyl)adenosine)
3,48941,13721513

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adams, JL; Carr, SA; Doyle, ML; Fisher, S; Gallagher, TF; Huddleston, MJ; Kassis, S; Kumar, S; Lee, JC; Livi, GP; McDonnell, PC; McLaughlin, MM; McNulty, D; Porter, TG; Seibel, G; Young, PR1

Other Studies

1 other study(ies) available for sb 203580 and 5'-(4-fluorosulfonylbenzoyl)adenosine

ArticleYear
Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site.
    The Journal of biological chemistry, 1997, May-02, Volume: 272, Issue:18

    Topics: Adenosine; Adenosine Triphosphate; Affinity Labels; Amino Acid Sequence; Binding Sites; Binding, Competitive; Calcium-Calmodulin-Dependent Protein Kinases; Calorimetry; Cloning, Molecular; Cross-Linking Reagents; Enzyme Inhibitors; Escherichia coli; HeLa Cells; Humans; Imidazoles; Kinetics; Mitogen-Activated Protein Kinases; Mutagenesis, Site-Directed; p38 Mitogen-Activated Protein Kinases; Pyridines; Recombinant Proteins; Saccharomyces cerevisiae

1997